Search companies

Live

Tuesday, 17 November 2026 · 583 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Papyrus Reports Improved TBS Samples As It Targets Commercial Production

PPY: $0.009 +0.00% · MC: $5M

Papyrus Australia says internal testing showed significantly improved performance in a second production-scale board run, with samples now sent to TBS for testing before any move to commercial supply. It also began engaging additional potential customers and says its FY27 priorities include completing TBS acceptance, scaling production and securing funding; shareholders approved all resolutions at the AGM.

Source announcements: 2026-10-30 08:02 to 2026-10-30 13:32 Sydney time
Story updated 2026-10-30 13:34 Sydney time
SourcesQuarterly Activities/Appendix 4C Cash Flow ReportFY26 AGM Executive Chair Address & CEO Update2026 AGM Poll Results
Comments